This transcript has been edited for clarity. Hello. I’m Dr Maurie Markman, from City of Hope. I would like to briefly discuss something I don’t normally...
The US Food and Drug Administration (FDA) has approved Onyda XR (clonidine hydrochloride) for the treatment of attention-deficit/hyperactivity disorder (ADHD), drug manufacturer Tris Pharma announced in...
In a recent study published in the journal BMC Medicine, researchers conducted a randomized controlled trial (RCT) to investigate whether short-term interventions combining alcohol-metabolizing enzyme substances,...